Lv3
400 积分 2025-07-25 加入
OP0043 WITHDRAWAL OF A LOW DOSE (5 MG) OF CORTICOSTEROIDS IN SYSTEMIC LUPUS IN REMISSION FOR MORE THAN A YEAR IS AT RISK OF RELAPSE – THE CORTICOLUP TRIAL
3小时前
求助中
Oxidative Stress and Cataract Formation: Evaluating the Efficacy of Antioxidant Therapies
19小时前
已完结
It hasn’t gone away: the problem of glucocorticoid use in lupus remains
22小时前
已完结
Analysis of the prevalence of cataracts and glaucoma in systemic lupus erythematosus and evaluation of the rheumatologists' practice for the monitoring of glucocorticoid eye toxicity
22小时前
已完结
CORTICOSTEROIDS AND CATARACTS
22小时前
已完结
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
4天前
已完结
The etiology of steroid cataract
5天前
已完结
Oxidative stress in the pathology and treatment of systemic lupus erythematosus
5天前
已完结
Incidence of Uveitis in Patients With Axial Spondylarthritis Treated With Biologics or Targeted Synthetics: A Systematic Review and Network Meta‐Analysis
1个月前
已完结
Venous Thromboembolism Risk With JAK Inhibitors: A Meta‐Analysis
1个月前
已完结
皖公网安备34019202002308
